Cycrimine (trade name Pagitane) is a central anticholinergic drug designed to reduce the levels of acetylcholine in the treatment of Parkinson’s disease. Its mechanism of action is to bind to the muscarinic acetylcholine receptor M1.
This page contains content from the copyrighted Wikipedia article "Cycrimine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
